STING Signaling Drives Production of Innate Cytokines, Generation of CD8 T Cells and Enhanced Protection Against Infection
Overview
Authors
Affiliations
A variety of signaling pathways are involved in the induction of innate cytokines and CD8 T cells, which are major players in protection against acute infection. Previous data have demonstrated that a TBK-1/IRF3-dependent signaling pathway promotes IFN-β production in response to , but the role for STING, a main interactor of these proteins, remained to be addressed. Here, we demonstrated that STING signaling is required for production of IFN-β, IL-6, and IL-12 in response to infection and that STING absence negatively impacts activation of IRF-dependent pathways in response to the parasite. We reported no significant activation of IRF-dependent pathways and cytokine expression in RAW264.7 macrophages in response to heat-killed trypomastigotes. In addition, we showed that STING is essential for DNA-mediated induction of IFN-β, IL-6, and IL-12 gene expression in RAW264.7 macrophages. We demonstrated that STING-knockout mice have significantly higher parasitemia from days 5 to 8 of infection and higher heart parasitism at day 13 after infection. Although we observed similar heart inflammatory infiltrates at day 13 after infection, IFN-β, IL-12, CXCL9, IFN-γ, and perforin gene expression were lower in the absence of STING. We also showed an inverse correlation between parasite DNA and the expression of CXCL9, IFN-γ, and perforin genes in the hearts of infected animals at day 13 after infection. Finally, we reported that STING signaling is required for splenic IFN-β and IL-6 expression early after infection and that STING deficiency results in lower numbers of splenic parasite-specific IFN-γ and IFN-γ/perforin-producing CD8 T cells, indicating a pivotal role for STING signaling in immunity to .
Inhibition Effect of STING Agonist SR717 on PRRSV Replication.
Si X, Wang X, Wu H, Yan Z, You L, Liu G Viruses. 2024; 16(9).
PMID: 39339849 PMC: 11437437. DOI: 10.3390/v16091373.
Gaikwad S, Srivastava S Mol Ther. 2024; 32(9):3145-3162.
PMID: 39097773 PMC: 11403213. DOI: 10.1016/j.ymthe.2024.07.029.
The pathogenesis and potential therapeutic targets in sepsis.
Zhang W, Jiang H, Wu G, Huang P, Wang H, An H MedComm (2020). 2023; 4(6):e418.
PMID: 38020710 PMC: 10661353. DOI: 10.1002/mco2.418.
Petcharat K, Munkong N, Thongboontho R, Chartarrayawadee W, Thim-Uam A J Exp Pharmacol. 2023; 15:407-421.
PMID: 37933302 PMC: 10625772. DOI: 10.2147/JEP.S433181.
Perumal N, White B, Sanchez-Valdez F, Tarleton R J Immunol. 2023; 211(7):1123-1133.
PMID: 37603014 PMC: 10783805. DOI: 10.4049/jimmunol.2300373.